home.social

#abbvieinc — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #abbvieinc, aggregated by home.social.

fetched live
  1. AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

    The healthcare sector is shifting as legacy blockbusters face competition from low-cost generics while new chronic care treatments…
    #NewsBeep #News #Healthcare #AbbVieInc #AU #Australia #CARDINALHEALTHINC #currentratio #freecashflow #Health #NovoNordisk #revenuegrowth
    newsbeep.com/au/888036/

  2. AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

    The pharmaceutical industry is shifting as legacy blockbusters lose patent protection. Investors must choose between AbbVie Inc (NYSE:ABBV)…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVieInc #Health #Pfizer #PfizerInc
    newsbeep.com/us/836853/

  3. AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?

    The pharmaceutical market is currently defined by a race to replace aging blockbusters with next-generation therapies. Deciding whether…
    #NewsBeep #News #Healthcare #AbbVieInc #AU #Australia #EliLilly #Health
    newsbeep.com/au/873847/

  4. AbbVie (ABBV) Wins Health Canada Approval for Boey

    AbbVie Inc. (NYSE:ABBV) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June…
    #Canada #ABBV #AbbVieInc. #AllerganAesthetics #Boey #Canaccord #glabellarlines
    europesays.com/canada/106825/

  5. Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?

    Sanofi’s SNY Dupixent, which it co-develops with Regeneron REGN, is its key top-line driver. The drug has transformed the treatment…
    #France #FR #Europe #EU #Sanofi #ABBV #AbbvieInc #futures #indexmarketquote #indexmarketquotes #indexmarketsymbol #indexmarketsymbols #indices #TheGlobeandMail
    europesays.com/france/39384/

  6. We’re increasing our price target on Bristol Myers after earnings and guidance top forecasts

    Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast…
    #Bristol #UnitedKingdom #UK #GB #England #Headlines #News #Europe #EU #AbbvieInc #BreakingNews:Markets #Bristol-MyersSquibbCo #Britain #businessnews #clubearnings #GreatBritain #Investmentstrategy #JimCramer #Johnson&Johnson #Markets #Merck&CoInc
    europesays.com/uk/744719/